- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hypoactive sexual desire dysfunction (HSDD)
- Meeting Date: November 2025
- Public Summary Document (PSD) November 2025 PBAC Meeting - (PDF 1.4MB)
- Public Summary Document (PSD) November 2025 PBAC Meeting - (Word 12.8MB)
Testosterone – November 2025
Testosterone: Transdermal cream 10 mg per mL, 50 mL; AndroFeme 1® - November 2025
Last updated
5 November 2025